| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $114.2M | +12.9% | +17.5% |
| SG&A Expense | $17.5M | -32.7% | -5.2% |
| Pre-tax Income | -$125.9M | -5.2% | -15.5% |
| Income Tax | $594K | -34.9% | +661.5% |
| Net Income | -$126.5M | -4.9% | -15.9% |
| EPS (Basic) | -$0.73 | -2.8% | +1.4% |
| EPS (Diluted) | -$0.73 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $521.9M | -12.9% | +10.3% |
| Accounts Receivable | $2.0M | +1.8% | +5.0% |
| Current Assets | $573.5M | -12.0% | +13.0% |
| Total Assets | $583.0M | -11.9% | +13.0% |
| Current Liabilities | $63.3M | +19.6% | -5.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$219.9M | -87.3% | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $27.5M | +842.9% | — |
| Free Cash Flow | -$219.9M | -87.3% | — |
| -2.8% |
| +1.4% |
| $63.3M |
| +19.6% |
| -5.1% |
| Stockholders' Equity | $519.7M | -14.6% | +15.7% |